<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
GOSS
Gossamer Bio
$
()


  • Gossamer Bio assumed with an Outperform at Wedbush

    4/4/2024 - 16:21pm
  • Piper Sandler pharmaceuticals analysts hold an analyst/industry conference call

    4/4/2024 - 12:10pm
  • Gossamer Bio reports Q4 EPS (21c), consensus (21c)

    3/5/2024 - 07:40am
  • Gossamer Bio price target raised by $5 at H.C. Wainwright, here's why

    1/8/2024 - 06:23am
  • Gossamer Bio appoints Bob Smith as Chief Commercial Officer

    12/5/2023 - 07:05am
  • Gossamer Bio price target lowered to 50c from $1.50 at Barclays

    11/10/2023 - 05:52am
  • Gossamer Bio reports Q3 EPS (21c), consensus (26c)

    11/9/2023 - 07:43am
  • Gossamer Bio management to meet with Piper Sandler

    10/12/2023 - 05:55am
  • Gossamer Bio management to meet with Piper Sandler

    10/11/2023 - 04:55am
  • Gossamer Bio management to meet with Piper Sandler

    10/10/2023 - 07:13am
  • Gossamer Bio files to sell 162.34M shares of common stock for holders

    8/18/2023 - 08:43am
  • Gossamer Bio files to sell 162.34M shares of common stock for holders

    8/17/2023 - 16:03pm
  • Gossamer Bio reports Q2 EPS (45c), consensus (49c)

    8/8/2023 - 16:04pm
  • Gossamer Bio downgraded to Neutral from Buy at UBS

    7/27/2023 - 08:35am
  • Gossamer Bio reports Q1 EPS (52c), consensus (53c)

    5/9/2023 - 16:15pm
dynamic_feed Breaking News